Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C M Kessler

Showing results (101-110 of 145) with videos related to

Pageof 15
Sort By:
Diseases of the Nervous System|January 1, 1975
Butaclamol hydrochloride (AY-23,028): an early evaluation in severely ill schizophrenicsD H Mielke, D M Gallant, T Oelsner, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 5, 2011
Survey of current prophylaxis practices and bleeding characteristics of children with severe haemophilia A in US haemophilia treatment centresM V Ragni, P J Fogarty, N C Josephson, et al.
Blood|June 1, 1984
Collagen-factor VIII/von Willebrand factor protein interactionC M Kessler, C M Floyd, M E Rick, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 1, 1995
Distribution and correlates of plasma fibrinogen in middle-aged women. Initial findings of the Postmenopausal Estrogen/Progestin Interventions (PEPI) studyM L Stefanick, C Legault, R P Tracy, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 16, 2010
von Willebrand factor: what is its role in the immune response in haemophilia?S Kaveri, P M Mannucci, M H Kurth, et al.
Lancet (London, England)|April 30, 1983
Abnormal T-lymphocyte subpopulations associated with transfusion of blood-derived productsC M Kessler, R S Schulof, A L Goldstein, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 7, 2005
B-domain deleted recombinant factor VIII preparations are bioequivalent to a monoclonal antibody purified plasma-derived factor VIII concentrate: a randomized, three-way crossover studyC M Kessler, J C Gill, G C White, et al.
American Journal of Clinical Pathology|May 1, 1995
Monitoring the anticoagulant effects of a low molecular weight heparin preparation. Correlation of assays in orthopedic surgery patients receiving ardeparin sodium for prophylaxis of deep venous thrombosisC M Kessler, I M Esparraguera, H M Jacobs, et al.
Cancer|February 1, 1985
Phenotypic and ultrastructural characterization of a medullary thymocyte acute lymphoblastic leukemia with cellular procoagulant activityT L Chorba, J M Orenstein, A B Ney, et al.
Journal of Thrombosis and Haemostasis : JTH|May 19, 2006
D-dimer, factor VIII coagulant activity, low-intensity warfarin and the risk of recurrent venous thromboembolismS Shrivastava, P M Ridker, R J Glynn, et al.
Pageof 15

Showing results (101-110 of 145) with videos related to

Sort By:
Pageof 15
Diseases of the Nervous System|January 1, 1975
Butaclamol hydrochloride (AY-23,028): an early evaluation in severely ill schizophrenicsD H Mielke, D M Gallant, T Oelsner, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 5, 2011
Survey of current prophylaxis practices and bleeding characteristics of children with severe haemophilia A in US haemophilia treatment centresM V Ragni, P J Fogarty, N C Josephson, et al.
Blood|June 1, 1984
Collagen-factor VIII/von Willebrand factor protein interactionC M Kessler, C M Floyd, M E Rick, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 1, 1995
Distribution and correlates of plasma fibrinogen in middle-aged women. Initial findings of the Postmenopausal Estrogen/Progestin Interventions (PEPI) studyM L Stefanick, C Legault, R P Tracy, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 16, 2010
von Willebrand factor: what is its role in the immune response in haemophilia?S Kaveri, P M Mannucci, M H Kurth, et al.
Lancet (London, England)|April 30, 1983
Abnormal T-lymphocyte subpopulations associated with transfusion of blood-derived productsC M Kessler, R S Schulof, A L Goldstein, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 7, 2005
B-domain deleted recombinant factor VIII preparations are bioequivalent to a monoclonal antibody purified plasma-derived factor VIII concentrate: a randomized, three-way crossover studyC M Kessler, J C Gill, G C White, et al.
American Journal of Clinical Pathology|May 1, 1995
Monitoring the anticoagulant effects of a low molecular weight heparin preparation. Correlation of assays in orthopedic surgery patients receiving ardeparin sodium for prophylaxis of deep venous thrombosisC M Kessler, I M Esparraguera, H M Jacobs, et al.
Cancer|February 1, 1985
Phenotypic and ultrastructural characterization of a medullary thymocyte acute lymphoblastic leukemia with cellular procoagulant activityT L Chorba, J M Orenstein, A B Ney, et al.
Journal of Thrombosis and Haemostasis : JTH|May 19, 2006
D-dimer, factor VIII coagulant activity, low-intensity warfarin and the risk of recurrent venous thromboembolismS Shrivastava, P M Ridker, R J Glynn, et al.
Pageof 15